SCHEDULE 13G Filed 2026-08-17 Event — SEC 0001831942-26-000041 →

Commodore Capital LP → InflaRx N.V. IFRX

Stake: — Shares: — Class: Ordinary Shares, nominal value 0.12 EUR per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 26.59

12,358,339 shares short · +2.1% vs prior

Other Filings by Commodore Capital LP

Filed	Form	Issuer	Stake	Shares
2026-10-07	SCHEDULE 13G	Sagimet Biosciences Inc.	—	—	view →
2026-10-01	SCHEDULE 13G	Surrozen, Inc./DE	—	—	view →
2026-09-02	SCHEDULE 13G	JATT III Acquisition Corp	—	—	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corp IV	—	—	view →
2026-06-18	SCHEDULE 13G	Avalo Therapeutics, Inc. AVTX	—	—	view →
2026-06-03	SCHEDULE 13G	EyePoint, Inc. EYPT	—	—	view →
2026-06-02	SCHEDULE 13G	Editas Medicine, Inc. EDIT	—	—	view →
2026-05-28	SCHEDULE 13G	Research Alliance Corp III RACC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →